首次静脉血栓栓塞后妊娠期间复发的危险因素:一项法国观察性研究
该前瞻性队列纳入189例15-49岁首次确诊静脉血栓栓塞的女性,随访至2000-2020年间随后一次至少20周的妊娠。妊娠期复发6例,产后复发11例;多变量分析仅肥胖与复发相关(OR 3.34,95%CI 1.11-10.05,p=.03)。作者认为肥胖孕妇低剂量抗凝可能不合适。
要点
- 妊娠期复发6例,其中孕早期5例、孕中期0例、孕晚期1例。
- 产后复发11例,发生率212.8/1000女性年(95%CI 119.9-349.1)。
- 多变量分析仅肥胖与复发相关,OR 3.34(95%CI 1.11-10.05,p=.03)。
核心结论
- 本研究证实有既往静脉血栓栓塞的女性产后复发风险高,尽管接受了血栓预防。
- 仅肥胖与妊娠期间静脉血栓栓塞复发相关,提示低剂量抗凝对肥胖孕妇可能不合适。
研究设计与样本
- 法国前瞻性队列研究,纳入189例15-49岁首次确诊静脉血栓栓塞的女性。
- 随访至2000-2020年间随后一次至少20周的妊娠,记录妊娠期复发及潜在临床危险因素。
主要发现
- 妊娠期复发6例:孕早期5例(发生率106.4/1000女性年,95%CI 46.3-226.0),孕中期0例,孕晚期1例(发生率27.0/1000女性年,95%CI 4.8-138.2)。
- 产后复发11例(发生率212.8/1000女性年,95%CI 119.9-349.1)。
- 17例复发中,肺栓塞±深静脉血栓5例,孤立性深静脉血栓12例。
- 血栓预防失败:妊娠期2例(33.3%),产后10例(90.9%)。
- 多变量分析仅肥胖(按孕前体质指数定义)与复发相关(OR 3.34,95%CI 1.11-10.05,p=.03)。
临床怎么用
- 作者认为,肥胖孕妇低剂量抗凝可能不合适。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Women with a previous venous thromboembolism (VTE) are at risk of recurrence during pregnancy. OBJECTIVES: We aimed to assess the incidence rate of recurrent VTE during pregnancy, according to the period of pregnancy, and the clinical parameters associated with recurrence, in a prospective cohort of women of childbearing age after a first VTE. PATIENTS/METHODS: A total of 189 women aged 15-49 years with a first documented VTE were followed until a subsequent pregnancy of at least 20 weeks' gestation between 2000 and 2020. VTE recurrences during pregnancy were recorded, as were potential clinical risk factors for recurrence. RESULTS: Recurrent VTE occurred in six women during antepartum: five during the first trimester (incidence rate 106.4 per 1000 women-years) (95% confidence interval [CI] 46.3-226.0); none during the second trimester; and one during the third trimester (incidence rate 27.0 per 1000 women-years [95% CI 4.8-138.2]). During postpartum, recurrences occurred in 11 women (incidence rate 212.8 per 1000 women-years [95% CI 119.9-349.1]). These 17 recurrent VTEs presented as pulmonary embolism ± deep vein thrombosis (DVT) in five patients and isolated DVT in 12. Failure of thromboprophylaxis occurred in two cases (33.3%) antepartum and in 10 cases (90.9%) postpartum. In multivariable analysis, only obesity (defined on prepregnancy body mass index) was associated with recurrent VTE (odds ratio 3.34 [95% CI 1.11-10.05, p = .03]). CONCLUSIONS: This study confirms a high risk of recurrent VTE postpartum, despite thromboprophylaxis, in women with a previous VTE. Only obesity was associated with VTE recurrence during pregnancy, suggesting that low-dose anticoagulation might not be appropriate in obese pregnant women.
引用
- de Moreuil C, Tromeur C, Daoudal A, et al. Risk factors for recurrence during a pregnancy following a first venous thromboembolism: A French observational study. J Thromb Haemost. 2022. PMID: 35020974. doi:10.1111/jth.15639
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。